Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
SNDXCompany Name
SYNDAX PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSYNDAX PHARMACEUTICALS INC - Enterprise Value over Free Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SNDX - EV/FCF Historical data
| Date | Enterprise Value | Enterprise Value over Free Cash Flow | Free Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ 1.13B | 0 | $ -302.67M |
| 3/31/2025 | $ 1.36B | 0 | $ -286.52M |
| 12/31/2024 | $ 1.52B | 0 | $ -274.9M |
| 9/30/2024 | $ 1.55B | 0 | $ -258.86M |
| 6/30/2024 | $ 1.77B | 0 | $ -241.19M |
| 3/31/2024 | $ 1.79B | 0 | $ -204.92M |
| 12/31/2023 | $ 1.78B | 0 | $ -160.6M |
| 9/30/2023 | $ 936.39M | 0 | $ -142.15M |
| 6/30/2023 | $ 1.32B | 0 | $ -125.81M |
| 3/31/2023 | $ 1.34B | 0 | $ -130.75M |
Key Performance Insights, Last 5 Years
- SYNDAX PHARMACEUTICALS INC's latest trailing twelve months (TTM) EV/FCF stands at 0.
- Over the past 5 years, SYNDAX PHARMACEUTICALS INC's average EV/FCF has been 47.05.
- The median EV/FCF for SYNDAX PHARMACEUTICALS INC during this period was 47.05
- SYNDAX PHARMACEUTICALS INC reached its highest EV/FCF over the past 5 years at 70.58.
- The lowest EV/FCF recorded by SYNDAX PHARMACEUTICALS INC in the same timeframe 23.53
SYNDAX PHARMACEUTICALS INC's EV/FCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV/FCF Benchmarks
Similar metrics to FCF:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
Definition of Enterprise Value over Free Cash Flow
[Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].EV / FCF
(=) EV/FCF EV/FCF for SYNDAX PHARMACEUTICALS INC is calculated as follows: EV [ $ 860.34M ] / FCF [ $ -68.36M ]
(=) EV/FCF [ 0 ] SNDX - Enterprise Value over Free Cash Flow, Last 5 years
23.53
Minimum
Dec 31, 2021
70.58
Maximum
Mar 31, 2022
47.05
Average
47.05
Median
EV/FCF Benchmark AnalysisMarket
The chart above depicts the distribution of EV/FCF for companies in the Total Stock Market. The average EV/FCF of the companies is 23.44 with a standard deviation of 16.12.
The following table provides additional summary stats:
EV/FCF in the Market:
| filtered constituents | 2.2K |
|---|---|
| min | 0.05 |
| max | 77.98 |
| average | 23.44 |
| median | 19.08 |
| std | 16.12 |